Recent Comments

Comment RSS

Search results for 'Ambien'


Computerized alerts induce clinicians to prescribe comparable generic equivalents Simple computerized alerts can help curb the impulse to prescribe unnecessarily expensive, heavily marketed drugs. A study in the August issue of Journal of General Internal Medicine found that when clinicians received computerized alerts, which compared medication brands, they changed 23.3 percent of prescriptions for four heavily marketed sleep medications to comparable generic equivalents. http://www.news-medical.net/news/20091110/Computerized-alerts-induce-clinicians-to-prescribe-comparable-generic-equivalents.aspx
USPTO issues Notice of Allowance to NovaDel Pharma NovaDel Pharma Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray technology. http://www.news-medical.net/news/20091106/USPTO-issues-Notice-of-Allowance-to-NovaDel-Pharma.aspx
Meda launches EDLUAR in the U.S. Meda Pharmaceuticals Inc. (Meda) today announced the commercial availability of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United States. EDLUAR is indicated for the short-term treatment of insomnia characterized by difficulties with falling asleep. EDLUAR is the first available under-the-tongue formulation of zolpidem tartrate, which is the most prescribed treatment for insomnia. Zolpidem tartrate is also the active ingredient in Ambien(R) oral tablets. http://www.news-medical.net/news/20090909/Meda-launches-EDLUAR-in-the-US.aspx
MRRI research study to investigate how zolpidem might restore consciousness for patients in the vegetative state Moss Rehabilitation Research Institute (MRRI), the research arm of MossRehab, one of the world’s leading clinical rehabilitation centers, has launched an ambitious research study to investigate how the sleep drug zolpidem might restore consciousness for patients in the vegetative state. http://www.news-medical.net/news/20090831/MRRI-research-study-to-investigate-how-zolpidem-might-restore-consciousness-for-patients-in-the-vegetative-state.aspx
Sharp increase in use of prescription sleep aids by young adults Use of prescription sleep aids nearly tripled among 18- to 24-year-olds between 1998 and 2006, according to a study released today by the Healthcare business of Thomson Reuters. http://www.news-medical.net/news/2009/01/19/45162.aspx
Save money wih generics Today, more than ever, consumers can opt for generic equivalents of brand-name medications at substantial cost savings. http://www.news-medical.net/news/2008/12/10/44039.aspx
WSJ examines drugmakers' use of 'unbranded product advertising' to promote disease awareness, treatment options The Wall Street Journal on Friday examined "unbranded product advertising" for brand-name drugs, which allow drugmakers to drive television viewers to Web sites promoting drugs without the requirement of listing the products' side effects in the TV advertisement. http://www.news-medical.net/news/2008/09/01/41069.aspx
Ranbaxy receives approval to manufacture Zolpidem tablets for insomnia Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg. http://www.news-medical.net/news/2007/04/27/24300.aspx
Mylan anounces FDA approval of Zolpidem Tartrate tablets Mylan Laboratories has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Zolpidem Tartrate Tablets, 5 mg and 10 mg. http://www.news-medical.net/news/2007/04/24/24051.aspx
FDA approves generic versions of Ambien The U.S. Food and Drug Administration (FDA) today approved the first generic versions of Ambien (zolpidem tartrate) immediate-release tablets. http://www.news-medical.net/news/2007/04/24/24037.aspx
Sedative-hypnotic drugs to get stronger warning labels The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks. http://www.news-medical.net/news/2007/03/14/22593.aspx
FDA warns consumers about buying medications over the Internet The Food and Drug Administration (FDA) in the United States has again warned consumers about buying medications over the Internet. http://www.news-medical.net/news/2007/02/19/21994.aspx
Scientists spot mechanism behind promising new sleep drug An experimental drug called gaboxadol may soon help millions of bleary-eyed insomniacs get to sleep, and a multi-center team of U.S. scientists believes they've pinpointed just how the drug works. http://www.news-medical.net/news/2006/11/01/20868.aspx
Prices on medications most commonly used by older people rose 4.3% in first half of 2006 Manufacturer prices for the brand-name drugs most commonly used by individuals ages 50 and older increased by an average of 6.3% during the 12-month period ending in June, according to an AARP survey released on Tuesday, the Newark Star-Ledger reports. http://www.news-medical.net/news/2006/09/22/20295.aspx
New sleep medication Ramelteon shows less potential to foster abuse and dependence As part of the effort to develop effective behavioral and medical sleep therapies, scientists consider the potential for dependence and abuse associated with prescription sleep drugs. http://www.news-medical.net/news/2006/06/27/18597.aspx
Strange behaviour blamed on sleeping pills Reports of some very strange behavior by insomniacs taking a prescribed sleeping pill have been of concern and have raised safety questions about insomnia medications. http://www.news-medical.net/news/2006/03/16/16697.aspx
FDA warns against buying prescription drugs on the net or overseas According to the U.S. Food and Drug Administration (FDA), consumers and healthcare professionals who fill out their prescriptions abroad are putting themselves at risk. http://www.news-medical.net/news/2006/01/17/15420.aspx
FDA approves Ambien CR for treatment of insomnia Sanofi-aventis announced today that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Ambien CR (zolpidem tartrate extended release) CIV. Ambien CR is the controlled-release formulation of zolpidem, the world's leading sleep aid. http://www.news-medical.net/news/2005/04/11/9149.aspx
Prescription drugs from bogus Canadian website are all fake A Food and Drug Administration (FDA) analysis of three commonly prescribed drugs purchased from a Web site advertised as Canadian showed that so-called "Canadian Generics" bought from the Web site were fake, substandard and potentially dangerous. http://www.news-medical.net/news/2004/07/15/3329.aspx
Basketball enthusiasts are on a losing streak when it comes to sleep Basketball enthusiasts are on a losing streak when it comes to sleep. A new poll shows that more than half (55%) of NBA fans watching the playoffs reported going to sleep later than normal on nights when they watched a game; of these, nearly 92% reported going to sleep an hour or more later than usual.(1) http://www.news-medical.net/news/2004/05/24/1848.aspx
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.